Chair and Associate Professor,
Department of Pharmaceutical Sciences and Administration
Prior to joining the University of New England School of Pharmacy, Leslie was a clinical pharmacist specialist in adult medicine at the Mountain Home VA Medical Center. During her time, she developed the medication reconciliation program for the facility and provided clinical insight for the multidisciplinary medicine teams. She precepted pharmacy students and residents in adult medicine and served as adjunct clinical faculty at the Bill Gatton College of Pharmacy at East Tennessee State University. She was a member of the VA National Medication Reconciliation Initiative and faculty for the Speaker's Bureau. Although, Leslie has spent most of her time as a clinical pharmacist in adult medicine she has experiences in other clinical settings that include neuro-intensive care, neurology, pediatrics and neonatal intensive care.
In addition, Leslie has held faculty appointments in the field of public health at the University of South Carolina and Western Washington University with a focus in epidemiology, community development, program planning and evaluation, women and children's health and rural health. Leslie has extensive experience designing, implementing, managing and evaluating large public health programs funded by the National Institutes of Health, Centers for Disease Control, Office of Substance Abuse and Prevention and the Children's Defense Fund. Other past employment includes experiences as the Associate Director for Xcenda, Inc., a contract and consulting organization that provides health outcomes and pharmacoeconomic services to pharmaceutical and biotechnology companies.
Pharmacist License (ME, NC, SC)
Evoy KE, Leonard CE, Covvey JR, Ochs L, Peckham AM, Soprano S, Reveles KR. Receipt of substance abuse use counseling among ambulatory patients prescribed opioids in the United States. Substance Abuse: Research and Treatment. 2020; 14:1-4.
Evoy KE, Covvey JR, Peckham AM, Ochs L, Hultgren KE. Reports of gabapentin and pregabalin abuse, misuse, dependence or overdose: An analysis of the Food and Drug Administration Adverse Events Reporting System (FAERS). Res Social Adm Pharm. 2019; 15(8):953-958.
Peckham AM, Evoy KE, Ochs L, Covvey JR. Gabapentin for off-label use: Evidence-based or cause for concern? Subst Abuse. 2018; 12:1-8.
Peckham AM, Evoy KE, Covvey JR, Ochs L, Fairman KA, Sclar DA. Predictors of gabapentin overuse with or without concomitant opioids in a commercially-insured US population. Pharmacotherapy 2018;38(4):436-443.
Jaramillo-Stametz J, Stewart H, Ochs L, Payne K. Multi-State medication take back initiative: Controlled substances collected from 2011-2015. J Subst Use 2018; 23(1):36-42.
DiPietro-Mager N, Ochs L, Ranelli P, Kahaleh A, Lahoz M, Patel R, Garza O, Isaacs D, Clark S. Partners in public health: A description of public health collaborations with schools of pharmacy. Public Health Reports; 2017;132(3):1-6.
Nichols S, McCall K, Ochs L, Holt C, Cattabriga G. Prescription monitoring program trends among individuals arrested in Maine for trafficking prescription drugs in 2014. Pharmacotherapy 2016; 36(6):585-589.
Dornblaser E, Ombengi D, Tofade T, Ratka A, Gleason S, Wigle PR, Zapantis A, Ryan M, Connor S, Jonkman L, Ochs L, Jungnickel P, Abrons JP. Current practices in global/international advanced pharmacy practice experiences: preceptor and student considerations. AJPE 2016; 80(3):1-11.
Stewart H, Malinoskwi A, Ochs L, McCall K, Sullivan M. Inside Maine’s medicine cabinet: Findings from DEA take-back programs, 2011-2013. Am J Public Health 2015; 105 (1): e65-e71.
Dangler M, Ochs L, and White R. Assessing the Appropriate Use of Proton Pump Inhibitors in a Veteran Outpatient Population. Federal Practitioner 2013; 30(5): 21-25.
Col NF, Ochs L, Springman V, Aragaki AK, Chlebowski R. Metformin and breast cancer risk: a meta-analysis and critical literature review. Breast Cancer Res Treat 2012; 135:639-646.
Other scholarly activity
Jarrett R, Hodges J, Lugo A, Ochs L. Belsomra (Suvorexant): New drug review. JAPhA 2016 (56): e100.
Nichols S, McCall K, Ochs L, Holt C, Cattabriga G. Prescription monitoring program among individuals arrested in Maine for trafficking prescription drugs in 2014. Pharmacotherapy 2015; 35(11): e210.
DiPietro-Mager N, Ochs L, Ranelli P, Kabaleh AA, Lahoz M, Patel RV, Garza OW, Issacs D, Clark S. Characterization of collaborations between Doctor of Pharmacy programs and public health departments and organizations. AJPE 2015; 79(5) S4:43.
Ochs L, Cattabriga G, Tu C, Pagnucco ML, Shah N, Ednacot K, Pha V, Kim J, Bolinaga J. Prescribing patterns and use of pain medications in women following orthopedic surgical procedures. Res Social Adm Pharm 2014; 10: e-46.
Kuhn E, Spielman R, Tu C, Koh, Ochs L. A simple and effective approach for analyzing multivariate longitudinal health outcomes in observational studies. Value in Health 2014; 17: A167.
Spielman R, Kuhn E, Tu C, Koh W, Ochs L. A comparison of propensity scores for assessing patient reported outcomes: A Monte Carlo study. Value in Health 2014; 17: A184.
Ochs L, Cattabriga G, Tu C, Pagnucco ML, Shah N, Ednacot K, Pha V, Kim J. Wide variations in prescribing patterns and use of pain medications following total knee arthroplasty in Maine. J Pain 2014;15(4) suppl 1:580.
Koepf ER, Larson C, Szymczuk C, Ochs L, Parsons P, Cattabriga, G. Medication use during pregnancy in the state of Maine. Contraception 2013; 88(2):312.
Col NF, Ochs L, Springman V, Aragaki AK, Chlebowski RT. Metformin and breast cancer risk: a meta-analysis and critical literature review. J Clin Oncology 30, no.27 suppl (September 2012) 25.
Covvey JR, Arya V, DiPietro Mager N, Gilman N, Herring M, Lukas S, Ochs L, Waddington L, eds. Public health in pharmacy practice: a casebook. 1st ed. Genesco, NY: Open SUNY Textbooks; 2020. Available at: https://courses.lumenlearning.com/suny-public-health-in-pharmacy-practice/.
Covvey JR, Ochs L, eds. Public health and epidemiology for pharmacy. 1st ed. San Diego, CA: Cognella; 2019.
Ochs L. An overview of public health. In: Covvey JR, Ochs L, eds. Public health and epidemiology for pharmacy. 1st ed. San Diego, CA: Cognella; 2019.
Ochs L. An overview of epidemiology. In: Covvey JR, Ochs L, eds. Public health and epidemiology for pharmacy. 1st ed. San Diego, CA: Cognella; 2019.
Ochs L. Cultural competency and health literacy. In: Covvey JR, Ochs L, eds. Public health and epidemiology for pharmacy. 1st ed. San Diego, CA: Cognella; 2019.
Health Resources and Service Administration--$996,261 (2014-2017); Community Access to Child Health in Maine (CATCH-ME). Co-Investigator (S. Cohen-Konrad, PI)
Medication use optimization and quality improvement